Table 2.
Sociodemographic and clinical characteristics of patients with long COVID-19, according to sleep symptoms
| No sleep disorder (n = 138) | Chronic Insomnia (n = 42) | Excessive Sleepiness (n = 6) | p | |
|---|---|---|---|---|
| Age (sd) | 44.9(± 46) | 49.7(± 28) | 41(± 30) | 0.350 |
| Males, n(%) | 50 (39) | 14(33) | 1(13) | 0.503 |
| Alcoholism, n(%) | 14(11) | 9(22) | 4(50) | 0.068 |
| COVID hospitalization, n(%) | 35(28) | 13(32) | 2(25) | 0.856 |
| Corticosteroid use, n(%) | 12(9) | 17(40) | 5(63) | <.001 |
| Headache, n(%) | 37(29) | 15(36) | 4(50) | 0.413 |
| Hypo/anosmia, n(%) | 37(29) | 20(48) | 1(13) | 0.064 |
| Depression, n(%) | 12(9) | 12(29) | 4(50) | <.001 |
| Anxiety, n(%) | 28(22) | 12(29) | 2(25) | 0.565 |
| Cognitve impairment, n(%) | ||||
| Dementia, n(%) | 10(7.8) | 0 | 0 | – |
| Subjective Cognitive | ||||
| Decline, n(%) | 63(48.8) | 33(78.6) | 5(83.3) | 0.005 |